Concepedia

Juntaro Yamasaki

JY

10

Publications

444

Citations

10

H-Index

2018

Active since

Affiliations

Keio University(Current)

Kumamoto University

Tokyo University of Science

Japanese Foundation For Cancer Research

Fujita Health University

Juntaro Yamasaki is an author at Keio University specializing in medicine, cancer research, and oxidative stress.

ORCID

Top concepts

Publications per year

2018–2024

10

Publications

10

Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma

Shogo Okazaki, Kiyoko Umene, Juntaro Yamasaki et al. · Cancer Science · 2019 · 84 citations · Full text

Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells

Shogo Okazaki, Subaru Shintani, Yuki Hirata et al. · Oncotarget · 2018 · 80 citations · Full text

, , +18

Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

Takahiko Akiyama, Tadahito Yasuda, Tomoyuki Uchihara et al. · Cancer Research · 2022 · 79 citations

Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer

Fumimasa Kitamura, Takashi Semba, Noriko Yasuda‐Yoshihara et al. · JCI Insight · 2023 · 73 citations · Full text

Epidermal growth factor receptor promotes glioma progression by regulating <scp>xCT</scp> and GluN2B‐containing <i>N</i>‐methyl‐<scp>d</scp>‐aspartate–sensitive glutamate receptor signaling

Kentaro Suina, Kenji Tsuchihashi, Juntaro Yamasaki et al. · Cancer Science · 2018 · 26 citations · Full text

Rows per page

1–5 of 10